Christopher Sj Probert (Chris Probert, Christopher Probert, Chris S Probert)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 14

Top Topics

Randomized Controlled Trial

Ulcerative Colitis

Iron Deficiency

Top Venues

Alimentary pharmacology & therapeutics

JGH open : an open access journal of gastroenterology and hepatology

BMJ open gastroenterology

British journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Phoebe A Thwaites, Rachael Slater, Christopher Sj Probert, Peter R Gibson
Recent advances in measuring the effects of diet on gastrointestinal physiology: Sniffing luminal gases and fecal volatile organic compounds. JGH open : an open access journal of gastroenterology and hepatology 8 (8) (2024)
Phoebe A Thwaites, Rachael Slater, Christopher Sj Probert, Peter R Gibson
Recent advances in measuring the effects of diet on gastrointestinal physiology: Sniffing luminal gases and fecal volatile organic compounds. JGH open : an open access journal of gastroenterology and hepatology 8 (8) (2024)
Bridgette Wilson, Tokuwa Kanno, Rachael Slater, Megan Rossi, Peter M Irving, Miranda C Lomer, Christopher Sj Probert, A James Mason, Kevin Whelan
Faecal and urine metabolites, but not gut microbiota, may predict response to low FODMAP diet in irritable bowel syndrome. Alimentary pharmacology & therapeutics (2023)
Lauren Lett, Michael George, Rachael Slater, Ben De Lacy Costello, Norman Ratcliffe, Marta García-Fiñana, Henry Lazarowicz, Christopher Sj Probert
Investigation of urinary volatile organic compounds as novel diagnostic and surveillance biomarkers of bladder cancer. British journal of cancer 127 (2) (2022)
Elizabeth Coates, Nyantara Wickramasekera, Amy Barr, Philip Shackley, Matthew James Lee, Prof Daniel Hind, Christopher Sj Probert, Shaji Sebastian, Nikki Totton, Sue Blackwell, Hugh Bedford, Nicola Dames, Alan Lobo
Patient preferences and current practice for adults with steroid-resistant ulcerative colitis: POPSTER mixed-methods study. Health technology assessment (Winchester, England) 26 (41) (2022)
Alice C Creedon, Eirini Dimidi, Estella S Hung, Megan Rossi, Christopher Sj Probert, Terri Grassby, Jesus Miguens Blanco, Julian R Marchesi, S Mark Scott, Sarah E Berry, Kevin Whelan
The Impact of Almonds and Almond Processing On Gastrointestinal Physiology, Luminal Microbiology and Gastrointestinal Symptoms: a Randomized Controlled Trial and Mastication Study. The American journal of clinical nutrition (2022)
Philip J Smith, Lisa Critchley, Daniel Storey, Belle Gregg, June Stenson, Andrew Kneebone, Tracy Rimmer, Stevena Burke, Shamas Hussain, Wan Yi Teoh, Stephan Vazeille, Solange Serna, Alan Steel, Edmund Derbyshire, Paul Collins, Martyn Dibb, Paul Flanagan, Christopher Sj Probert, Ajay Mark Verma, Sreedhar Subramanian
Efficacy and Safety of Elective Switching from Intravenous to Subcutaneous Infliximab [CT-P13]: A Multicentre Cohort Study. Journal of Crohn's & colitis 16 (9) (2022)
Awad Mahalhal, Michael D Burkitt, Carrie A Duckworth, Georgina L Hold, Barry J Campbell, David Mark Pritchard, Christopher Sj Probert
Long-Term Iron Deficiency and Dietary Iron Excess Exacerbate Acute Dextran Sodium Sulphate-Induced Colitis and Are Associated with Significant Dysbiosis. International journal of molecular sciences 22 (7) (2021)
Ashley Bond, Christopher Sj Probert
Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission - confounded by the gut microbiome? Authors' reply. Alimentary pharmacology & therapeutics 49 (8) (2020)
Christopher Sj Probert
Commentary: vitamin D supplementation in Crohn's disease. Alimentary pharmacology & therapeutics 51 (1) (2020)
Tristan Townsend, Christopher Sj Probert
Editorial: peristomal pyoderma gangrenosum-a challenge for patients, healthcare professionals and research. Alimentary pharmacology & therapeutics 52 (2) (2020)
Bernie Carter, Alison Rouncefield-Swales, Lucy Bray, Lucy Blake, Stephen J Allen, Christopher Sj Probert, Kay Crook, Pamela Qualter
"I Don't Like to Make a Big Thing out of It": A Qualitative Interview-Based Study Exploring Factors Affecting Whether Young People Tell or Do Not Tell Their Friends about Their IBD. International journal of chronic diseases 2020 (2020)
Ashley Bond, Rosemary Greenwood, Stephen Lewis, Bernard M Corfe, Sanchoy Sarkar, Paul O'Toole, Paul Rooney, Michael Burkitt, Georgina L Hold, Christopher Sj Probert
Volatile organic compounds emitted from faeces as a biomarker for colorectal cancer. Alimentary pharmacology & therapeutics 49 (8) (2019)
Christopher Sj Probert, Shaji Sebastian, Daniel R Gaya, P John Hamlin, Gillian Gillespie, Anita Rose, Helen Tate, Colin Wheeler, Peter M Irving
Golimumab induction and maintenance for moderate to severe ulcerative colitis: results from GO-COLITIS (Golimumab: a Phase 4, UK, open label, single arm study on its utilization and impact in ulcerative Colitis). BMJ open gastroenterology 5 (1) (2018)